Correction: Computational identification of aspartic protease inhibitors for antimalarial drug development against Plasmodium Vivax. [PDF]
Alruwaili M +3 more
europepmc +1 more source
Effectiveness of tafenoquine and primaquine for radical cure of Plasmodium vivax: a meeting report from dissemination of results of the EFFORT trial to stakeholders in Pakistan. [PDF]
Qurashi B +17 more
europepmc +1 more source
The reticulocyte restriction: invasion ligand RBP1a of <i>Plasmodium vivax</i> targets human TfR1, prohibitin-2, and basigin. [PDF]
Molina-Franky J +4 more
europepmc +1 more source
Safety and Efficacy of 3 Alternative Regimens Against Relapsing Plasmodium vivax Malaria in Glucose 6-Phosphate Dehydrogenase-Deficient Patients in the Brazilian Amazon (ALTPRIM). [PDF]
Barbosa L +31 more
europepmc +1 more source
<i>Plasmodium vivax</i> infection-driven modulation of sterol carrier protein reveals a metabolic link to reproductive physiology in <i>Anopheles stephensi</i>. [PDF]
Kumari S +7 more
europepmc +1 more source
Moving towards high-dose primaquine or single-dose tafenoquine for Plasmodium vivax treatment in Cambodia: a meeting report from dissemination of results of the EFFORT trial to stakeholders. [PDF]
Dysoley L +52 more
europepmc +1 more source
Preliminary assessment of serum endocan as a biomarker of disease severity in Plasmodium falciparum and Plasmodium vivax malaria. [PDF]
Nantavisai K +2 more
europepmc +1 more source
Malária incubada: a mixed methods analysis on knowledge and experiences on Plasmodium vivax and asymptomatic malaria infections in a hard-to-reach and mobile population in the Amazon. [PDF]
Plessis L +10 more
europepmc +1 more source

